secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biofrontera Inc. (BFRI)
CIK:        0001858685
Form:       8-K
Filed at:   2025-10-23T23:59:59+00:00
Accession:  0001493152-25-019006
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biofrontera closes purchase of Ameluz/RhodoLED US assets, reduces earnout to 12-15%
--------------------------------------------------------------------------------

- Acquired all U.S. assets and rights to Ameluz and RhodoLED, including NDA, patents, manufacturing, and personnel.
- New earnout structure: 12% of net sales up to $65M, 15% above; replaces prior 25-35% perpetual payment.
- Closing released final $2.5M of $11M financing led by existing investors Rosalind Advisors and AIGH.
- Biofrontera AG receives 10% post-money equity stake in Biofrontera Inc., aligning long-term interests.
- Company expects full asset and personnel transfer by late Q4 2025 or early Q1 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858685/000149315225019006/0001493152-25-019006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858685/000149315225019006/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-019006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer